Eve Health Group Limited · ASX:EVE

Eve Health — Investor Presentation (March 2018)

20 slides from Eve Health's investor presentation, Mar 13, 2018

  1. Slide 1: Medical Nutrition Investment Company

    For personal use only Medical Nutrition Investment Company

  2. Slide 2: Investment Focus

    The picture can't be displayed. For personal use only Investment Focus Eve’s vision is to be a leading Australia Investment company in the rapidly growing Global Medical Nutrition sector. Investing in businesses Identifying products Preference for in the early growth that have a unique natural organ

  3. Slide 3: Global Focus – Current Investments

    The picture can't be displayed. For personal use only Global Focus – Current Investments Canada United Kingdom USA China Australia

  4. Slide 4: Investments – Current

    The picture can't be displayed. For personal use only Investments – Current 50% 40% Potential new acquisitions

  5. Slide 5: Meluka Health – Business Structure

    The picture can't be displayed. For personal use only Meluka Health – Business Structure Option to Acquire 100% 100% US Distribution 2,100 acres of Organic Medicinal TGA licensed business. organic tea tree Honey Producer. contract plantation, Developing unique manufacturer. including approx product

  6. Slide 6: Meluka Honey – Current Update

    The picture can't be displayed. For personal use only Meluka Honey – Current Update  Established organic honey production • Hives installed on old growth plantation to produce medicinal honey. • Targeted production of 100 tons per year within 1 year.  Organic honey supply from the Bungawalbyn Vall

  7. Slide 7: Meluka Honey – Initial Product Range

    The picture can't be displayed. For personal use only Meluka Honey – Initial Product Range

  8. Slide 8: Meluka Honey – Next Months

    The picture can't be displayed. For personal use only Meluka Honey – Next 12 Months  Launch of Meluka Honey e-commerce website with initial product offering.  Direct to Consumer marketing campaign commences in the US.  Completion of Bee Health research by Southern Cross University for development

  9. Slide 9: EcoBotanicals – Current Update

    The picture can't be displayed. For personal use only EcoBotanicals – Current Update  Contract manufacturing of organic oil based products for established client base  Expanding manufacturing capability for Meluka Honey products.  TGA licensed and with requisite organic accreditations.  Securing

  10. Slide 10: EcoBotanicals – Next Months

    The picture can't be displayed. For personal use only EcoBotanicals – Next 12 Months  Manufacturing focus will centre on Meluka Health product range  Expand capacity of Honey manufacturing to meet expected demand.  Formulation of Medicinal Cannabis Honey  Development of “own” range of natural pr

  11. Slide 11: Omni Medical Nutrition - Current Update

    The picture can't be displayed. For personal use only Omni Medical Nutrition - Current Update  Distribution and Sales of Pre-meal drink for diabetes into China via agreement with Eagle Health (ASX: EHH) has commenced. • Eagle Health have invested $3.1m and committed a further $5.7m for factory, war

  12. Slide 12: Omni Innovation Near Future (12 Months)

    The picture can't be displayed. For personal use only Omni Innovation Near Future (12 Months)  China sales and revenue numbers for the Hutang 1 product manufactured and Distributed by Eagle Health to be released.  Complete Formulation of new low calorie diet drink with Alan Barclay.  Complete pro

  13. Slide 13: Summary

    The picture can't be displayed. Summary  Medical Nutrition sector growing rapidly and For personal use only competing with traditional pharmaceuticals.  Eve is well exposed to the sector via it’s diabetes, weight loss and general wellness investments  Global appeal of Medical Nutritional products

  14. Slide 14: Thank you

    The picture can't be displayed. For personal use only Thank you

  15. Slide 15: Appendix - Eve Investments Structure

    The picture can't be displayed. Appendix 1 - Eve Investments Structure ASX listed healthcare investment company (ASX Code: EVE) For personal use only Capital Structure Ordinary Shares: 2,198,870,299 Options/Rights 100,050,000 (various exercise prices) Market Cap: $22m (6 March 2018) Cash: $4.2m (6 M

  16. Slide 16: Appendix - Old Growth Tea Tree Plantation

    The picture can't be displayed. For personal use only Appendix 2 - Old Growth Tea Tree Plantation • The Melaleuca tea tree is known globally for its medicinal properties, in particular it’s anti microbial, anti inflammatory power. The most common application has been through the use of its oil. • By

  17. Slide 17: Appendix - Interesting facts

    The picture can't be displayed. Appendix 3 - Interesting facts Bee populations are declining globally with For personal use only estimates suggesting a 44% decline in global bee populations caused by Bee health issues. Around a third of global food New Zealand’s natural honey exports have grown supp

  18. Slide 18: Appendix - Pre-Meal Drink Validation

    The picture can't be displayed. For personal use only Appendix 4 - Pre-Meal Drink Validation Acute Response of blood glucose to pre-meal drink Long term impact on HbA1c to pre-meal drink

  19. Slide 19: Appendix – Global Incidence of Diabetes

    The picture can't be displayed. For personal use only Appendix 5 – Global Incidence of Diabetes Source: IDF Diabetes Atlas Seventh Edition 2015

  20. Slide 20: Appendix - Disclaimer

    The picture can't be displayed. Appendix 6 - Disclaimer For personal use only • The information contained in this presentation is not financial product advice. The presentation is for information purposes and is of a general and summary nature only. It does not constitute an offer. EVE Investments L

Eve Health Group — Investor Presentation (March 2018) on 6ix